> **来源：[研报客](https://pc.yanbaoke.cn)** # CPIC (2601 HK) Summary ## Core Content CPIC (China Pacific Insurance Co., Ltd.) reported strong first-half of 2026 (1H26) results, with robust financial performance across key metrics. The company declared its first interim dividend, signaling a renewed focus on shareholder returns. The analysis includes key financial figures, valuation insights, and risk factors for the stock. ## Main Financial Highlights - **Group Net Profit**: Increased by 10.4% YoY to RMB30.8bn, with a 13.6% YoY rise in 2Q26 (vs. 4.3% in 1Q26). - **Group OPAT**: Rose 6.2% YoY to RMB21.1bn, with 2Q26 OPAT up 8.9% YoY (vs. 3.6% in 1Q26). - **Net Asset Value (NAV)**: Grew 5.6% HoH to RMB319.2bn, remaining broadly stable QoQ. - **Group EV**: Increased 3.8% HoH to RMB637bn, with Life EV up 4.1% HoH to RMB485bn. - **CPIC P&C CoR**: Improved to 95.1% in 1H26, up 1.3pct YoY, leading to a 35.7% YoY increase in UW profit to RMB4.8bn. - **CPIC Life NBV**: Grew 12.7% YoY to RMB10.8bn, driven by margin expansion to 17.5% (+2.5pct YoY), though partially offset by a -2.6% YoY drop in FYP. - **Agency NBV**: Rose 23.4% YoY to RMB7.07bn, supported by a 28.4% YoY increase in FYP and 23.2% YoY growth in FYRP. - **Bancassurance NBV**: Declined 10.6% YoY to RMB3.2bn, mainly due to a steep drop in single-paid premiums (-51.4% YoY). ## Key Metrics and Forecasts - **EPS Forecasts**: Revised upwards by 3%/7%/8% to RMB5.77/6.13/6.56 for FY26-28E. - **Dividend Yield**: Expected to rise to 4.9% in FY26E, with a 19.1% OPAT payout for the first interim dividend. - **Valuation**: - Current P/EV: 0.4x FY26E - Current P/B: 0.7x FY26E - Target Price (TP): HK\$44.00, up from HK\$40.00, implying 0.6x P/EV and 1.2x P/B. - **Valuation Approach**: - CPIC Life: 0.74x P/EV based on appraisal value. - CPIC P&C: 0.8x P/B using the P/B-ROE method. - AM and other segments: 1.0x P/B with a 15% conglomerate discount. ## Risk Factors 1. Prolonged low-interest rate environment 2. Intensified equity market volatilities 3. Weaker-than-expected new business sales volumes 4. NBV margin deterioration 5. Intensified P&C industry competition ## Share Performance - **Current Price**: HK\$30.22 - **Market Cap**: HK\$290,726.7m - **1-month return**: -1.1% - **3-month return**: -3.8% - **6-month return**: -15.9% ## Shareholding Structure - **Ping An Insurance Group**: 12.1% - **JPMorgan Chase & Co.**: 11.4% ## Valuation Table | Metric | FY26E (RMB bn) | FY27E (RMB bn) | FY28E (RMB bn) | |--------------------------|---------------|---------------|---------------| | Net Profit | 56.935 | 59.199 | 63.596 | | EPS (Reported) | 5.77 | 6.13 | 6.56 | | Consensus EPS | 5.67 | 5.99 | 6.39 | | P/Embedded Value (x) | 0.4 | 0.3 | 0.3 | | Dividend Yield (%) | 4.9 | 5.4 | 5.9 | | ROE (%) | 17.2 | 15.9 | 14.8 | ## Analyst Recommendations - **CMBIGM Rating**: BUY - **Target Price**: HK\$44.00 (up from HK\$40.00) - **Potential Return**: Over 15% over the next 12 months ## Conclusion CPIC demonstrated strong performance in 1H26, with improved net profit, OPAT, and EV. The company is focusing on shareholder returns with its first interim dividend and has raised its EPS forecasts. The stock is currently undervalued based on its P/EV and P/B ratios, and the target price suggests a positive outlook. However, the company faces several risks, including a low-interest rate environment, equity volatility, and competitive pressures in the P&C sector.